Background: The pathogenesis of sarcoidosis involves T cells and B lymphocytes that
produce autoantibodies. We compared the expression of different T and B cell subsets in …

Clinical phenotypes, by examining relationships between several domains in sarcoidosis,
are likely to better delineate the underlying processes and pathways. Larger studies with …

Sarcoidosis is a multisystem, granulomatous disease that most often affects the lungs. The
clinical course is highly variable; many patients undergo spontaneous remission, but up to a …

Sarcoidosis has been a disease of puzzling occurrence and clinical course. Multiple
immunological markers have been noted to be altered within sarcoidosis, however there is …

Introduction: Sarcoidosis is a chronic granulomatous inflammatory disease that commonly
causes lung disease, but can affect other vital organs and tissues. The cause of sarcoidosis …

Sarcoidosis is a granulomatous inflammatory disorder, primarily affecting the lungs, first
described by Sir Jonathan Hutchinson in 1877 (1). Since that time, clinicians and …

Sarcoidosis is a multisystem granulomatous disease with many unsolved mysteries,
including its cause 8 and cure (1). The heterogeneity of sarcoidosis, including multisystemic …

Sarcoidosis, a multisystemic immune disease, significantly impacts patients' quality of life.
The complexity and diversity of its pathogenesis, coupled with limited comprehensive …

Sarcoidosis is considered the archetype of immune granulomatous disorders, since
immunoregulatory mechanisms that play a part in the development of the sarcoid granuloma …

Sarcoidosis is a systemic inflammatory disease characterized by development of
granulomas in the affected organs. Sarcoidosis is often a diagnosis of exclusion, and …